Teladoc Health merges with Livingo to improve the standards in Healthcare

GlobeNewswire | August 05, 2020

Teladoc Health (TDOC), the global leader in virtual care, and Livongo (LVGO), the leading Applied Health Signals company – today announced that they have entered into a definitive merger agreement. This merger represents a transformational opportunity to improve the delivery, access and experience of healthcare for consumers around the world. The highly complementary organizations will combine to create substantial value across the healthcare ecosystem, enabling clients everywhere to offer high quality, personalized, technology-enabled longitudinal care that improves outcomes and lowers costs across the full spectrum of health.

Spotlight

Power the future of routine surgeries. High-quality imaging, high uptime and efficient workflow in a powerfully compact design.

Spotlight

Power the future of routine surgeries. High-quality imaging, high uptime and efficient workflow in a powerfully compact design.

Related News

HEALTHCARE ANALYTICS

AmerisourceBergen Announces Pharmacy Telehealth Partnership with SteadyMD

businesswire | May 05, 2023

AmerisourceBergen (AB), a global healthcare company, has announced a strategic partnership with SteadyMD, a B2B telehealth infrastructure provider that powers high-quality telehealth patient experiences for leaders and innovators in healthcare. The two organizations have kicked off their collaboration with the cocreation of a telehealth solution focused on Test to Treat opportunities. The solution is being offered as a pilot to independent community pharmacies across the US. “The Test to Treat initiative is an important acknowledgement of the role of pharmacists and pharmacies as accessible healthcare providers and destinations,” said Jenni Zilka, Senior Vice President, Good Neighbor Pharmacy Field Programs & Services at AmerisourceBergen. “In order for pharmacies to continue making a sustainable impact on the communities they serve, we need to continue providing them the tools, resources, and authority to provide necessary clinical services, where appropriate. AmerisourceBergen’s exploration of a telehealth solution with SteadyMD to enhance the scope of the Test to Treat model is just one way we’re continuing to support the important role of the pharmacist in the healthcare ecosystem.” AmerisourceBergen’s telehealth solution is being developed to expand the number of Test to Treat services that independent pharmacies can offer to patients. The Test to Treat initiative was launched in 2022 to help provide quick and equitable access to COVID-19 testing and treatment in the early days of infection. The model is intended to provide a seamless patient experience and designed to reach high-risk, underserved populations. With its telehealth solution, AmerisourceBergen is evaluating the long-term viability of the Test to Treat model for use cases, beyond COVID-19, to improve access to treatment. The pilot program has been launched across a group of 130 independent retail pharmacies, including members of the Good Neighbor Pharmacy network. Over a span of 12 weeks, pilot participants will utilize the SteadyMD platform to provide patients with a quick and accessible Test to Treat option within their pharmacy, at an affordable price. Patients can test for an illness or condition and then, if deemed necessary by a SteadyMD physician, consult with them on demand through the telehealth platform and receive a prescription for treatment. "We're excited to embark on a commercial partnership with AmerisourceBergen and welcome the company to our supportive family of investors," said Guy Friedman, CEO of SteadyMD. "As we continue our mission to save leaders and innovators in healthcare time, money, and resources by helping them stand up their telehealth practices, AmerisourceBergen’s collaboration and investment will further strengthen our best-in-class technology, clinical operations, and nationwide clinician workforce, while bolstering our unwavering commitment to becoming the backbone powering modern healthcare." “AmerisourceBergen has an ongoing commitment to delivering innovation for its customers and aligning with organizations that are transforming healthcare through bold thinking, solutions, and programs,” said Jason Dinger, SVP of Global Product and Solutions at AmerisourceBergen. “Working with SteadyMD, we look forward to collaborating on a telehealth offering to help our pharmacy customers drive value for their patients and their bottom lines.” Pharmacies participating in the telehealth pilot program can use the solution to help patients obtain COVID-19 oral antiviral therapies, as appropriate. AmerisourceBergen and SteadyMD will continuously evaluate opportunities to expand use cases during and after the program. In addition to the commercial partnership, AmerisourceBergen has also made an investment in SteadyMD through its venture fund AB Health Ventures. About AmerisourceBergen AmerisourceBergen is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 44,000+ worldwide team members contribute to positive health outcomes through the power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue.

Read More

AI, DIGITAL HEALTHCARE

TeleVox Launches AI-Enabled Omnichannel Conversational Virtual Assistant for Healthcare Providers

Globenewswire | April 18, 2023

TeleVox, an industry-leading provider of omnichannel digital patient technology, unveiled its latest innovation at the HIMSS Conference (April 17-19). Iris™ is the newest addition to the company's end-to-end digital patient engagement platform, HouseCalls Pro. Iris is a powerful AI-driven virtual agent accessible via web, voice, and SMS interactions and embedded into HouseCalls Pro patient engagement workflows. Utilizing Microsoft Azure OpenAI Service with its large-scale, generative AI models and other chat technology, Iris provides patients with quick access to information and easy completion of common tasks, improving patient access and self-service. Iris enables call deflection and reduces operational burden and costs for health systems. When necessary, Iris can seamlessly connect patients with a live agent chat for timely and accurate assistance. Iris sets a new standard for conversational virtual assistants by surpassing current basic chatbots that utilize limited content, require extensive training, and lack an EHR-integrated, omnichannel experience. With its advanced AI capabilities and access to a vast range of published content, Iris can provide immediate responses to a wide range of patient queries, making it the most comprehensive solution available. By integrating voice, web chat, and SMS capabilities into a single omnichannel experience, healthcare providers can offer self-service options to patients for a variety of common activities, reducing the burden on staff and increasing patient acquisition. Iris is highly flexible and can be easily integrated with existing EHRs or deployed as a standalone solution, ensuring a seamless patient engagement experience. "As a leader in patient engagement technology for over three decades, TeleVox has continuously strived to enhance the patient experience and care through innovation," said Vik Krishnan, President of TeleVox. "Iris, a new generation of AI-enabled patient-provider communication, marks a significant milestone in the evolution of patient engagement technology and enables health systems to deliver the self-service experience that consumers expect today.” Iris integrates a full range of communication technologies, including web chat, conversational SMS messaging, and automated telephone responses, providing patients with the flexibility to engage with healthcare providers on their own terms. Unlike other chatbot solutions that can leave patients feeling frustrated by dead-end conversations, Iris will seamlessly connect patients with a live representative should they require further assistance. Moreover, healthcare organizations can easily incorporate their website and other content into the automated system, providing patients with customized and easy-to-understand "FAQ" content in natural language. By leveraging Iris's advanced AI and chat technologies, patients will receive real-time responses to their questions, reducing response times and increasing patient satisfaction. “Healthcare providers face immense challenges in managing the patient care journey, from providing high-quality care to increasing visit volumes and revenue streams while simultaneously reducing staff workload,” said Kamal Anand, Chief Product Officer, TeleVox. “Iris, with its use of Azure OpenAI Service and chat technologies, is the solution that healthcare organizations need to meet these challenges.” “Microsoft’s advancements in AI are grounded in our company’s mission to help every person and organization on the planet to achieve more,” said Brian Willson, Vice President, West & Midwest region, Microsoft. “TeleVox is embracing this mission by improving patient experiences and mitigating staff burnout in healthcare, using Microsoft Azure OpenAI Service to develop innovative solutions that can make a real difference in people's lives." KLAS, a leading analyst in the patient engagement space, provided additional comments on the announcement. “Technology advances through AI and other tools have created opportunity to significantly improve patient engagement,” said Adam Cherrington, Vice President Digital Health at KLAS. “It’s critical that healthcare organizations identify and leverage platforms that significantly enhance the patient experience while addressing serious operational shortfalls.” About TeleVox TeleVox is a leading provider of omnichannel digital patient engagement technology. Our solutions are used by more than 10,000 healthcare organizations—from hospitals and health systems to community health centers—to engage, educate, and empower patients throughout their care journey. Our patient engagement platform integrates with the electronic health record (EHR) to support automated, personalized, two-way interactions with patients. And our pharmaceutical team partners with life science companies to develop strategic disease state awareness, education, and vaccination reminders by reaching more patients through customized communication. All of these exchanges are possible via text, virtual assistant, interactive voice response (IVR), email, and postcards. For 30 years, TeleVox has helped preserve care continuity, reduce the operational burden on staff, and drive revenue while making the healthcare communication process easier for everyone.

Read More

HEALTH TECHNOLOGY, DIGITAL HEALTHCARE

WellSky® Unveils Patient Engagement Platform to Personalize Condition Management and Optimize Health Outcomes

Businesswire | April 10, 2023

WellSky, a leading health and community care technology company, today announced the launch of WellSky Patient, a transformative patient engagement platform aimed at identifying patient health risks, avoiding complications, and improving outcomes through stronger transparency and communication between patients, families, and clinical care teams. A patient’s willingness and ability to participate in their care plans, particularly between provider visits, can greatly influence whether they experience new health problems and subsequent use of costly, unplanned emergent care. With the WellSky Patient platform, patients stay connected to their care providers between visits through two-way communication, video-based telehealth, and guided condition management programs. At the same time, patient-generated data from health status submissions and remote monitoring creates a comprehensive view for clinicians to track a patient’s progression and identify needs for clinical intervention. “It is critical that our care team members have a complete picture of the patient’s condition and are given the insights necessary to engage most appropriately with the right resources at the right time,” said Dr. Bethany Snider, chief medical officer at Hosparus Health. “The capabilities WellSky is bringing to the table help give us the visibility we need to customize care to the individual, while also ensuring the patient’s family members and other caregivers are full participants in the care journey.” When patients are given convenient and practical tools to help them take an active role in their own care and well-being, satisfaction is higher, complications are fewer, and outcomes are better. By focusing on the home as the center of patient engagement, healthcare organizations can gain new insights into patient behaviors and conditions, enabling them to adjust the plan of care, control costs, and positively influence outcomes to the benefit of the person and the healthcare organization alike. “Patient engagement technology has historically focused on completing tasks related to a care episode, such as scheduling an appointment, completing an intake form, or viewing a lab result,” said Tim Ashe, chief clinical officer at WellSky. “That paradigm must shift toward the person, with a focus on how to best guide them through the care journey while surveying and managing their condition virtually. The innovation WellSky has developed to bring this strategy to life will be of great value to our clients, their care team members, and their patients.” By putting the person at the center of their own care, healthcare organizations can offer unique and differentiated care experiences while gaining unprecedented insights into when – and how – specific interventions can optimize outcomes for patients and ultimately ensure success in models of value-based care. About WellSky® WellSky is one of America’s largest and most innovative healthcare technology companies leading the movement for intelligent, coordinated care. Our proven software, analytics, and services power better outcomes and lower costs for stakeholders across the health and community care continuum. In today’s value-based care environment, WellSky helps providers, payers, health systems, and community organizations scale processes, improve collaboration for growth, harness the power of data analytics, and achieve better outcomes by further connecting clinical and social care. WellSky serves more than 20,000 client sites — including the largest hospital systems, blood banks, cell therapy labs, home health and hospice franchises, post-acute providers, government agencies, and human services organizations. Informed by more than 40 years of providing software and expertise, WellSky anticipates clients’ needs and innovates relentlessly to build healthy, thriving communities.

Read More